Zurich Cantonal Bank
XERS icon

Zurich Cantonal Bank’s Xeris Biopharma Holdings XERS Stock Holding History

Zurich Cantonal Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$541K Buy
93,302
+27,535
+42% +$183K ﹤0.01% 1793
2025
Q4 		$516K Buy
65,767
+33,115
+101% +$261K ﹤0.01% 1765
2025
Q3 		$266K Buy
32,652
+29,353
+890% +$195K ﹤0.01% 2064
2025
Q2 		$15.4K Sell
3,299
-365
-10% -$1.67K ﹤0.01% 2494
2025
Q1 		$20.1K Buy
+3,664
New +$14.8K ﹤0.01% 2558
2023
Q3 		– Sell
-12
Closed -$31 – 2802
2023
Q2 		$31 Hold
12
– – ﹤0.01% 2789
2023
Q1 		$20 Sell
12
-8,107
-100% -$10.1K ﹤0.01% 2847
2022
Q4 		$10.8K Sell
8,119
-1,713
-17% -$2.42K ﹤0.01% 2800
2022
Q3 		$15K Hold
9,832
– – ﹤0.01% 2838
2022
Q2 		$15K Sell
9,832
-919
-9% -$1.94K ﹤0.01% 2826
2022
Q1 		$28K Buy
+10,751
New +$26.3K ﹤0.01% 2627

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return